Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 2,051 | 1,523 | 230 | 168 | 0 |
| Gross Profit | 2,051 | 1,523 | 230 | 168 | N/A |
| Operating Expenses | 38,665 | 33,563 | 31,577 | 26,471 | 9,816 |
| Operating Income | -36,614 | -32,040 | -31,347 | -26,303 | -9,816 |
| Other Income | 2,551 | 965 | 281 | 6,667 | 111 |
| Pre-tax Income | -34,063 | -31,075 | -31,066 | -19,636 | -9,705 |
| Income Tax | -29 | -13 | -636 | -13,973 | N/A |
| Net Income Continuous | -34,034 | -31,062 | -30,430 | -5,663 | -9,705 |
| Net Income | $-34,034 | $-31,062 | $-30,430 | $-5,663 | $-9,705 |
| EPS Basic Total Ops | -4.18 | -3.71 | -3.65 | -0.93 | -9.79 |
| EPS Basic Continuous Ops | -4.18 | -3.71 | -3.65 | -0.84 | -7.45 |
| EPS Diluted Total Ops | -4.18 | -3.71 | -3.65 | -0.93 | -9.79 |
| EPS Diluted Continuous Ops | -4.18 | -3.71 | -3.65 | -0.84 | -7.45 |
| EPS Diluted Before Non-Recurring Items | -4.18 | -3.71 | -3.65 | -0.93 | -9.27 |
| EBITDA(a) | $-36,570 | $-31,991 | $-31,130 | $-25,719 | $-9,779 |